Average Co-Inventor Count = 3.01
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eli Lilly and Company (5 from 4,447 patents)
2. Warner-lambert Company (2 from 2,538 patents)
3. Elanco US Inc. (2 from 42 patents)
4. Pfizer Corporation (1 from 4,455 patents)
10 patents:
1. 12234239 - Crystalline forms of 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile
2. 11548895 - Process for making crystalline 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile
3. 10323019 - Pyrazolylaminobenzimidazole derivatives as JAK inhibitors
4. 9790177 - Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, gamma-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
5. 9624218 - Pyrido[2,3-d]pyrimidin-4-one compounds as tankyrase inhibitors
6. 9522923 - Selective BACE1 inhibitors
7. 9156824 - CDC7 inhibitors
8. 8648200 - Imidazole derivatives useful for the treatment of arthritis
9. 8563750 - Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylmino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
10. 8026376 - Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoicacid calcium salt (2:1)